This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Avedro, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations in Drug Delivery: The Contributions of Stephen Zolla
Introduction
Stephen Zolla is an accomplished inventor based in Bedford, MA (US). He has made significant contributions to the field of drug delivery systems, particularly for ocular applications. His innovative approach has the potential to enhance the effectiveness of treatments for eye conditions.
Latest Patents
Stephen Zolla holds a patent for "Systems and methods for delivering drugs to an eye." This patent describes a drug delivery device that includes a drug-eluting element defined by a plurality of outer surfaces, including a delivery surface and one or more non-delivery surfaces. The delivery surface is designed to be positioned against the tissue of the eye, targeting specific areas for drug administration. The device holds the drug when not in contact with the tissue and releases it when the delivery surface is applied to the targeted area. Additionally, the device features barrier structures that inhibit drug release through non-delivery surfaces, ensuring precise delivery.
Career Highlights
Stephen Zolla is currently associated with Avedro, Inc., where he continues to develop innovative solutions in drug delivery. His work has been instrumental in advancing technologies that improve patient outcomes in ocular therapies. With a focus on practical applications, Zolla's inventions are paving the way for more effective treatment options.
Collaborations
Stephen has collaborated with notable colleagues, including Pavel Kamaev and Alexandra Nicklin. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies in the medical field.
Conclusion
Stephen Zolla's contributions to drug delivery systems exemplify the impact of innovation in healthcare. His patented technologies are set to revolutionize the way medications are administered to the eye, ultimately improving patient care.
